Market revenue in 2023 | USD 178.3 million |
Market revenue in 2030 | USD 319.3 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Instruments |
Fastest growing segment | Software |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Instruments was the largest segment with a revenue share of 34.38% in 2023. Horizon Databook has segmented the India flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
In the last few decades, India has become a hub of pharmaceutical and biotechnology companies and has gained global attention due to the presence of skilled & knowledgeable manpower and low capital investments.
Owing to the presence of rich resources and a large pool of existing R&D institutions in the country, India has become one of the major areas for setting up research laboratories and manufacturing units by multinational companies.
In addition, public sector enterprises, such as Biotechnology Industry Research Assistance Council (BIRAC) and the Department of Biotechnology (DBT), have promoted R&D in the field of biotechnology across the country. Thus, rapidly growing pharmaceutical and biotechnology industries and frequent government initiatives to boost R&D activities in the country are expected to create lucrative opportunities for the growth of flow cytometry market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account